BioCentury
ARTICLE | Clinical News

DR-70 ELISA regulatory update

October 22, 2007 7:00 AM UTC

ADL submitted a 510(k) application to FDA for its DR-70 ELISA test as an aid in monitoring patients previously diagnosed with colorectal cancer. The in vitro immunoassay kit detects the level of fibri...